SEATTLE, April 13, 2012 (GLOBE NEWSWIRE) -- Attorney Advertising. Keller Rohrback L.L.P. (www.krcomplexlit.com/investigations/beyaz-safyral-yasmin-and-yaz-birth-control-pills">www.krcomplexlit.com) announces that it is investigating the birth controls pills Beyaz, Safyral, Yasmin, and Yaz, all of which are products of Bayer Healthcare, a division of Bayer AG. These birth control pills have been linked to serious and dangerous side-effects, including, but not limited to the following: pulmonary embolism; blood clot; deep vein thrombosis; and heart attack.
On April 10, 2012, the United States Food and Drug Administration (FDA) announced that it had completed its review of studies regarding the risk of blood clots in women taking birth control pills such as Beyaz, Safyral, Yasmin, and Yaz. The FDA confirmed that such pills are associated with a higher risk of blood clots and recommends that women should talk to their doctor about their risk for blood clots before deciding on which birth control method to use.
If you or someone you know has been seriously harmed as a result of taking Beyaz, Safyral, Yasmin, or Yaz, or you would like additional information regarding this investigation, please contact attorneys Amy Hanson or Mike Woerner at (800) 776-6044 or via email at info@kellerrohrback.com.
Keller Rohrback L.L.P. has successfully represented hundreds of clients injured by prescription drugs such as Fen-Phen, Baycol, and Vioxx. Our Complex Litigation Group is proud to offer its expertise in personal injury cases to clients nationwide. Keller Rohrback's trial lawyers have obtained judgments and settlements on behalf of clients in excess of seven billion dollars.
Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome.